Commit To Purchase Akcea Therapeutics At $15, Earn 22.8% Annualized Using Options
February 13, 2020 at 11:51 AM EST
Investors considering a purchase of Akcea Therapeutics Inc (AKCA) stock, but cautious about paying the going market price of $17.58/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July put at the $15 strike, which has a bid at the time of this writing of $1.45..